Outcome of a three-phase treatment algorithm for inpatients with melancholic depression-Reference-Cited by-同舟云学术

Outcome of a three-phase treatment algorithm for inpatients with melancholic depression

Published:2018-06 Issue: Volume:84 Page:214-220
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Vermeiden Marlijn,Kamperman Astrid M.,Hoogendijk Witte J.G.,van den Broek Walter W.,Birkenhäger Tom K.

Funder

Erasmus Medical Center

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference29 articles.

1. Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review;Adli;Biol. Psychiatry,2006

2. How effective is algorithm-guided treatment for depressed inpatients? Results from the randomized controlled multicenter German algorithm project 3 trial;Adli;Int. J. Neuropsychoparmacol.,2017

3. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability;Anderson;J. Affect. Disord.,2000

4. Efficacy of an algorithm-guided treatment compared with treatment as usual, a randomized, controlled study of inpatients with depression;Bauer;J. Clin. Psychopharmacol.,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eletroconvulsoterapia: eficácia, mecanismos e considerações éticas no tratamento da depressão grave;Europub Journal of Health Research;2024-08-02

2. Systematic review of structured care pathways in major depressive disorder and bipolar disorder;BMC Psychiatry;2023-02-02

3. Hydrothermal synthesis of ZnO nanoflowes for rapid detection of sertraline and imipramine using the modified screen-printed electrode;Journal of Materials Science: Materials in Electronics;2022-08-10

4. Psychopharmacology Algorithms for Major Depressive Disorder: Current Status;Major Depressive Disorder;2021

5. Epidemiology, Etiology, Screening, Psychotherapy of Malignant Tumor Patients with Secondary Depressive Disorder;Current Pharmaceutical Design;2018-10-19